More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$10.60B
EPS
-0.84
P/E ratio
--
Price to sales
1.59
Dividend yield
--
Beta
0.935309
Previous close
$15.39
Today's open
$15.45
Day's range
$15.42 - $15.76
52 week range
$7.27 - $16.38
show more
CEO
Emmanuel Ligner
Employees
13500
Headquarters
Radnor, PA
Exchange
New York Stock Exchange
Shares outstanding
676358840
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
VTRS vs. AVTR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Viatris (VTRS) or Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors?
Zacks Investment Research • Oct 6, 2026

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, and will hold a related conference call on the same day at 8:00 a.m.
PRNewsWire • Oct 1, 2026

Avantor appoints new Chief Financial Officer
RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.
PRNewsWire • Sep 21, 2026

Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Zacks Investment Research • Sep 21, 2026

Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.
Zacks Investment Research • Sep 18, 2026

Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
Zacks Investment Research • Sep 16, 2026

Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Zacks Investment Research • Sep 4, 2026

Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Aug 28, 2026

Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.
Zacks Investment Research • Aug 25, 2026

Is Avantor (AVTR) Outperforming Other Medical Stocks This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Zacks Investment Research • Aug 19, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Avantor Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.